Literature DB >> 25451166

Smoothened activates breast cancer stem-like cell and promotes tumorigenesis and metastasis of breast cancer.

Lixia Wang1, Wei Duan2, Le Kang3, Jun Mao1, Xiaotang Yu1, Shujun Fan1, Lianhong Li4, Yajun Tao5.   

Abstract

Smoothened (Smo) is a G protein-coupled receptor protein encoded by the Smo gene of the hedgehog signalling pathway, which is thought to play an important role in maintaining organ patterning, cell differentiation and self-renewal. The possible role of Smo in the process of tumorigenesis and metastasis of breast cancer still remains unclear. The present experiments were to investigate the effect of Smo on activating breast cancer stem-like CD44(+)CD24(-) cells and the tumorigenesis and metastasis of breast cancer. By injected CD44(+)CD24(-) cells (1×10(4)) into the cleared fat pad of NOD/SCID mice, it was observed that CD44(+)CD24(-) cells possess higher tumor-initiating capacity and metastasis properties than equal numbers of non-CD44(+)CD24(-) cells. The mRNA and protein expressions of Smo in CD44(+)CD24(-) cells were higher than those in non-CD44(+)CD24(-) cells, indicating that Smo may play a role in maintaining breast cancer stem cell features. qRT-PCR results revealed that expressions of STAT3, Bcl-2 and cyclinD1 mRNA in MCF-7 cells were decreased after transfected by Smo siRNA. In addition, the expressions of MMP-2 and MMP-9 were downregulated in MCF-7 cells after Smo expression was inhibited. Smo inhibition may be a possible therapeutic target that potentially suppresses breast tumor formation and development.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Breast cancer stem-like cells; Metastasis; Smoothened (Smo); Tumorigenesis

Mesh:

Substances:

Year:  2014        PMID: 25451166     DOI: 10.1016/j.biopha.2014.09.012

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

Review 1.  Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells.

Authors:  Kirti S Prabhu; Afsheen Raza; Thasni Karedath; Syed Shadab Raza; Hamna Fathima; Eiman I Ahmed; Shilpa Kuttikrishnan; Lubna Therachiyil; Michal Kulinski; Said Dermime; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

Review 2.  Breast cancer stem cell: the roles and therapeutic implications.

Authors:  Fang Yang; Jing Xu; Lin Tang; Xiaoxiang Guan
Journal:  Cell Mol Life Sci       Date:  2016-08-16       Impact factor: 9.261

3.  Inhibition of Hedgehog Delays Liver Regeneration through Disrupting the Cell Cycle.

Authors:  Jiawang Tao; Yan Chen; Yuanqi Zhuang; Ruzhi Wei; Anteneh Getachew; Tingcai Pan; Fan Yang; Yinxiong Li
Journal:  Curr Issues Mol Biol       Date:  2022-01-18       Impact factor: 2.976

4.  Regulation of Cellular and Cancer Stem Cell-Related Putative Gene Expression of Parental and CD44+CD24- Sorted MDA-MB-231 Cells by Cisplatin.

Authors:  May Zie Koh; Wan Yong Ho; Swee Keong Yeap; Norlaily Mohd Ali; Lily Boo; Noorjahan Banu Alitheen
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-21

5.  Silencing of long non‑coding RNA NEAT1 inhibits hepatocellular carcinoma progression by downregulating SMO by sponging microRNA‑503.

Authors:  Chuihua Sun; Ting Xiao; Ying Xiao; Yunbao Li
Journal:  Mol Med Rep       Date:  2021-01-05       Impact factor: 2.952

Review 6.  Signaling pathways governing breast cancer stem cells behavior.

Authors:  Kai Song; Maryam Farzaneh
Journal:  Stem Cell Res Ther       Date:  2021-04-16       Impact factor: 6.832

Review 7.  Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer.

Authors:  Cenzhu Wang; Kun Xu; Runtian Wang; Xin Han; Jinhai Tang; Xiaoxiang Guan
Journal:  J Exp Clin Cancer Res       Date:  2021-11-20

Review 8.  The biology and role of CD44 in cancer progression: therapeutic implications.

Authors:  Chen Chen; Shujie Zhao; Anand Karnad; James W Freeman
Journal:  J Hematol Oncol       Date:  2018-05-10       Impact factor: 17.388

9.  OCT4 accelerates tumorigenesis through activating JAK/STAT signaling in ovarian cancer side population cells.

Authors:  Zhengyi Ruan; Xingyu Yang; Weiwei Cheng
Journal:  Cancer Manag Res       Date:  2018-12-28       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.